Hinge Health, Inc. (HNGE) Stock

About Hinge Health, Inc.

Hinge Health, Inc. is headquartered in US.

Hinge Health, Inc. (HNGE) stock trades at $111.52 with a market capitalization of $9.00B. The stock is valued at a price-to-earnings (P/E) ratio of 73.04, price-to-book of 22.51, price-to-sales of 10.57. Over the past 52 weeks the stock has ranged between $30.08 and $112.00, and currently trades at or near its 52-week high.

On profitability, Hinge Health, Inc. generates a return on equity (ROE) of 30.25%, above the typical market range of roughly 12-15%, return on capital employed of 27.08%, an operating margin of -81.60%, a net profit margin of 15.15%.

Hinge Health, Inc. by the numbers, 2023–2025

Between 2023 and 2025 Hinge Health, Inc. reported revenue of $293.0M rising to $588.0M, a change of +100.7% across 3 years. Compounded, revenue has grown —% a year over five years, —% over three, 50.8% over the last twelve months. Net profit fell to $-528.0M.

Operating margin went from -44.6% in 2023 to -92.9% in 2025, a fall of 48.3 percentage points. The most recent net margin is 15.15%. On a trailing twelve-month basis to Jun '26, revenue is $720.0M and net profit $109.0M.

Borrowings fell from $16.0M to $8.0M, cash on hand is $317.3M, cash from operations was $171.0M in the latest year, positive in 2 of the last 3.

Return on equity has averaged -55.8% over five years, and was -139.3% in the most recent year.

The share price itself has compounded at —% a year over five years, —% over three, 93.0% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

Hinge Health, Inc. (HNGE) — frequently asked questions